NVCN Neovasc Inc. gains 42% Oct 5, 2017

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch biological tissue products that are used as components in third-party medical products, such as transcatheter heart valves for industry partners and other customers. In addition, it offers a line of collagen-based surgical patch products for use in cardiac reconstruction and vascular repair procedures, as well as other surgeries. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. http://www.priceseries.com/trade/NVCN-Neovasc-Inc-stock-gains-42-percent-a-Trade-Record-by-priceSeries-2017091120171005.html